LPTI.US Longport Inc

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Oct 26, 2026
0.0001 0.0001
Market cap
USD 2.31K
P/E
-
P/B
-
ROE
-132.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2005.

Is LPTI.US undervalued?

Graham number

The Graham number of Longport Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Longport Inc fundamental analysis

No fundamental analysis for Longport Inc yet.

Longport Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Longport Inc

Longport, Inc. develops, manufactures, markets, and sells high resolution ultrasound imaging systems primarily in the United States. It offers EPISCAN I-200, a high frequency ultrasound imaging system that utilizes ultrasound at frequencies between 20 and 50MHz to image the skin and underlying soft tissue. The company's products are used in wound assessment, wound prevention, dermatology, and aesthetics/plastics, as well as in various other applications. It also exports its …

Full company profile